Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

Author： Ardon Hilko   Gool Stefaan   Lopes Isabel   Maes Wim   Sciot Raf   Wilms Guido   Demaerel Philippe   Bijttebier Patricia   Claes Laurence   Goffin Jan   Calenbergh Frank   Vleeschouwer Steven  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.99, Iss.2, 2010-09, pp. : 261-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

By Balaña Carmen   López-pousa Antonio   Berrocal Alfonso   Yaya-tur Ricardo   Herrero Ana   García Jose-luis   Martín-broto Javier   Benavides Manuel   Cerdá-nicolás Miguel   Ballester Rosa   Balart Josep   Capellades Jaume  

Journal of Neuro-Oncology, Vol. 70, Iss. 3, 2004-12 ,pp. : 359-370

Springer Publishing Company

Access to resources Recommend Favorite

Autologous Dendritic Cell Based Adoptive Immunotherapy of Patients with Colorectal Cancer—A Phase I-II Study

By Hunyadi János   András Csilla   Szabó Imre   Szántó János   Szluha Kornélia   Sipka Sándor   Kovács Péter   Kiss Attila   Szegedi Gyula   Altorjay István   Sápy Péter   Antal-Szalmás Péter   Tóth László   Fazekas György   Rajnavölgyi Éva  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 357-365

Springer Publishing Company

Access to resources Recommend Favorite

Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate

By Vilella R.   Benítez D.   Milà J.   Lozano M.   Vilana R.   Pomes J.   Tomas X.   Costa J.   Vilalta A.   Malvehy J.   Puig S.   Mellado B.   Martí R.   Castel T.  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 651-658

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

By Peereboom David   Shepard Dale   Ahluwalia Manmeet   Brewer Cathy   Agarwal Neeraj   Stevens Glen   Suh John   Toms Steven   Vogelbaum Michael   Weil Robert   Elson Paul   Barnett Gene  

Journal of Neuro-Oncology, Vol. 98, Iss. 1, 2010-05 ,pp. : 93-99

Springer Publishing Company

Access to resources Recommend Favorite

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

By Eisele Günter   Wick Antje   Eisele Anna-Carina   Clément Paul   Tonn Jörg   Tabatabai Ghazaleh   Ochsenbein Adrian   Schlegel Uwe   Neyns Bart   Krex Dietmar   Simon Matthias   Nikkhah Guido   Picard Martin   Stupp Roger   Wick Wolfgang   Weller Michael  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite